Frazier Life Sciences Management, L.P. Alpine Immune Sciences, Inc. Transaction History

Frazier Life Sciences Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$8.54 - $20.22 $1.24 Million - $2.94 Million	145,251 Added 4.86%	3,131,008 $59.7 Million
Q2 2022 Aug 10, 2022	SELL	$6.71 - $9.52 $8.05 Million - $11.4 Million	-1,200,000 Reduced 28.67%	2,985,757 $25.4 Million
Q1 2022 May 16, 2022	BUY	$6.41 - $13.89 $26.8 Million - $58.1 Million	4,185,757 New	4,185,757 $37.5 Million

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Frazier Life Sciences Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Frazier Life Sciences Management, L.P. with notifications on news.